SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCI is trending amidst mixed reactions to its earnings report and future guidance, sparking debate about its valuation and management. While the company projects substantial revenue growth in the AI server market, concerns linger around margins and historical performance, leading to community discussions on whether the dip presents a buying opportunity or signals deeper issues.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

UPST is trending downwards as investors react to concerns about the company's loan portfolio and broader macroeconomic uncertainty, despite some community members citing the potential for a short squeeze. Discussions center on the impact of potential government shutdowns and future interest rate cuts. Some believe UPST is undervalued, while others express concerns about the company's business model and its ability to compete in the AI lending space.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

VTI is trending amidst market volatility driven by concerns surrounding AI stock valuations, potential economic downturns, and escalating trade tensions, particularly involving Trump's tariff policies. Community discussions revolve around navigating market uncertainty and the safety of broad-based ETFs like VTI, with some considering shifts to more defensive sectors like healthcare. Recent news highlights individual stock performances within the ETF and broader discussions around company-specific catalysts.

Hertz Global Holdings, Inc. engages in the vehicle rental business through the Hertz, Dollar, and Thrifty brands. It operates under the Americas Rental Car (RAC) and International Rental Car (RAC) segments. The Americas RAC segment focuses on operations in the United States, Canada, Latin America, and the Caribbean. The International RAC segment includes the provision of rental and sales of vehicles and value-added services in other locations. The company was founded in 1918 and is headquartered in Estero, FL.

Hertz Global Holdings Inc. - Ordinary Shares (New)

Hertz is trending due to positive earnings news, sparking excitement among retail traders who see potential for a short squeeze. Community discussions focus on the high short interest and comparison to past squeeze events like Carvana. With a turnaround story and notable institutional investment, the stock is garnering attention as a potential high-reward play.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

CSIQ is trending as investors discuss the overnight surge of its China-based CSI Solar subsidiary to new all-time highs, fueling speculation about potential arbitrage opportunities. Community members are actively debating the valuation mismatch between CSIQ and CSI Solar, with some pointing to a possible short squeeze. Additionally, there are rumors circulating about a potential sale of CSIQ's Recurrent Energy arm, further driving interest in the stock.

Arista Networks, Inc. engages in the development, marketing, and sale of cloud networking solutions. Its solutions include EOS, a set of network applications, and Gigabit Ethernet switching and routing platforms. Its product categories include Core, Cognitive Adjacencies, and Network Software and Services. The company was founded by Andreas Bechtolsheim, David Cheriton, and Kenneth Duda in November 2004 and is headquartered in Santa Clara, CA.

Arista Networks Inc

Arista Networks is trending as investors digest recent earnings and analyst upgrades, while also focusing on the company's position in the AI infrastructure buildout. Community discussions revolve around the stock's strong fundamentals and growth potential, particularly within the networking and data center sectors. Some traders are capitalizing on dips, viewing them as buying opportunities amidst broader conversations about AI-related valuations.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk ($NVO) is trending amid discussions around earnings, guidance, and a potential bidding war with Pfizer to acquire Metsera. Community talking points include speculation about the impact of the new CEO, potential deal with TrumpRx, and the possibility of the FDA approving an oral version of Wegovy. Overall sentiment appears mixed, with some investors viewing the current price as undervalued while others express concern about the company's future prospects amidst increasing competition.

SSgA Active Trust - SPDR Dow Jones Industrial Average ETF

The DIA is trending amid optimism surrounding potential US-China trade deal advancements and anticipation for the Fed's upcoming rate decision. Community members are closely monitoring economic data and earnings reports from major tech companies, with some expressing concerns about the sustainability of the market's rally and potential for a pullback. There is also discussion around the influence of AI on the market and its concentration in a few key stocks.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Vir Biotechnology is trending as investors digest recent clinical trial data and the initiation of a Phase 3 registrational program for its Hepatitis Delta treatment. Community discussions focus on the company's progress in Hepatitis therapies, its financial position, and the potential impact of recent developments on its stock valuation. Some are concerned by insider selling and broader market conditions while others remain optimistic about Vir's long-term prospects and potential for a turnaround.

Uber Technologies, Inc. is a technology platform, which engages in the development and operation of technology applications, networks, and product to power movement from point A to point B. The firm offers ride services and merchants delivery service providers for meal preparation, grocery, and other delivery services. It operates through the following segments: Mobility, Delivery, and Freight. The Mobility segment refers to products that connect consumers with Mobility Drivers who provide rides in a variety of vehicles, such as cars, auto rickshaws, motorbikes, minibuses, or taxis. The Delivery segment offers consumers the chance to search for and discover local restaurants, order a meal, and either pick-up at the restaurant or have the meal delivered. The Freight segment focuses on connecting Carriers with Shippers on its platform, and gives Carriers upfront, transparent pricing, and the ability to book a shipment. The company was founded by Oscar Salazar Gaitan, Travis Kalanick, and Garrett Camp in 2009 and is headquartered in San Francisco, CA.

Uber Technologies Inc

Recent earnings and growth metrics have $UBER trending, though some investors are wary after an initial dip despite strong results; community members are actively debating whether the company is undervalued given its buyback program and long-term prospects. Discussions also highlight Uber's strategic positioning in the autonomous vehicle space and its potential impact on the broader market, though some express concern about profitability and competition.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$XXII Achieve Life Sciences&#39; (ACHV) cytisinicline is considered a potential improved smoking cessation drug successor to Chantix (varenicline) , Chantix annual global sales peaked at $1.4 billion in 2010. The drug quickly became a blockbuster for Pfizer. Cytisinicline would be the first new FDA-approved prescription treatment option for smoking cessation in nearly 20 years, filling a significant gap in the market.  
 
Studies supported by researchers from Massachusetts General Hospital (MGH) have shown that the smoking cessation drug cytisinicline has a favorable tolerability profile compared to Chantix.  
 
The U.S. Food and Drug Administration (FDA) has set a PDUFA target action date of June 20, 2026 (target date when the FDA intends to make an approval decision), for its New Drug Application. 
 
Pending FDA approval, a commercial launch in the U.S. is expected in the second half of 2026.  
 
Vaping Cessation: ACHV has a rare FDA Commissioner&#39;s National Priority  Vocher.

StockTwits Web

22nd Century Group Inc

 Achieve Life Sciences' (ACHV) cytisinicline is considered a potential improved smoking cessation drug successor to Chantix (varenicline) , Chantix annual global sales peaked at $1.4 billion in 2010. The drug quickly became a blockbuster for Pfizer. Cytisinicline would be the first new FDA-approved prescription treatment option for smoking cessation in nearly 20 years, filling a significant gap in the market.  
 
Studies supported by researchers from Massachusetts General Hospital (MGH) have shown that the smoking cessation drug cytisinicline has a favorable tolerability profile compared to Chantix.  
 
The U.S. Food and Drug Administration (FDA) has set a PDUFA target action date of June 20, 2026 (target date when the FDA intends to make an approval decision), for its New Drug Application. 
 
Pending FDA approval, a commercial launch in the U.S. is expected in the second half of 2026.  
 
Vaping Cessation: ACHV has a rare FDA Commissioner's National Priority  Vocher.

@Deeconomics deec0n0mics..im feelin a tum0r gr0win just l00kin at the drug ur menti0nin..humm..ill pass 0n thet chemical s0up..thx..truly.xtp

StockTwits For Android 

 deec0n0mics..im feelin a tum0r gr0win just l00kin at the drug ur menti0nin..humm..ill pass 0n thet chemical s0up..thx..truly.xtp

Butt cap

@Xtp Cytisinicline is a potential blockbuster drug that will help many stop smoking &quot;including the handful of VLN smokers&quot;. How are VLN sales doing 🤔 It&#39;s indisputable how XXII retail investors losses, ridiculous reverse stock splits and &quot;CORRUPETENT&quot; (Combination of Corrupt &amp; Incompetent) XXII corporate leadership are negating public health and retail investors gains chances and failing public health and retail investors in an unprecedented manner. Any reasonably prudent person without a personal agenda WANTS any method of  smoking cessation to be successful to save lives. XXII Delusion Conclusion!

 Cytisinicline is a potential blockbuster drug that will help many stop smoking "including the handful of VLN smokers". How are VLN sales doing 🤔 It's indisputable how XXII retail investors losses, ridiculous reverse stock splits and "CORRUPETENT" (Combination of Corrupt & Incompetent) XXII corporate leadership are negating public health and retail investors gains chances and failing public health and retail investors in an unprecedented manner. Any reasonably prudent person without a personal agenda WANTS any method of  smoking cessation to be successful to save lives. XXII Delusion Conclusion!